These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 22876913)
1. Structural dynamics of V3 loop with different electrostatics: implications on co-receptor recognition: a molecular dynamics study of HIV gp120. Chandramouli B; Chillemi G; Giombini E; Capobianchi MR; Rozera G; Desideri A J Biomol Struct Dyn; 2013 Apr; 31(4):403-13. PubMed ID: 22876913 [TBL] [Abstract][Full Text] [Related]
2. Importance of V3 loop flexibility and net charge in the context of co-receptor recognition. A molecular dynamics study on HIV gp120. Chandramouli B; Chillemi G; Abbate I; Capobianchi MR; Rozera G; Desideri A J Biomol Struct Dyn; 2012; 29(5):879-91. PubMed ID: 22292949 [TBL] [Abstract][Full Text] [Related]
3. Structural dynamics of V3 loop in a trimeric ambiance, a molecular dynamics study on gp120-CD4 trimeric mimic. Chandramouli B; Chillemi G; Desideri A J Struct Biol; 2014 Apr; 186(1):132-40. PubMed ID: 24583235 [TBL] [Abstract][Full Text] [Related]
4. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor. Labrosse B; Treboute C; Brelot A; Alizon M J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952 [TBL] [Abstract][Full Text] [Related]
5. On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition. Lamers SL; Fogel GB; Liu ES; Salemi M; McGrath MS AIDS Res Hum Retroviruses; 2016 Aug; 32(8):829-40. PubMed ID: 27071630 [TBL] [Abstract][Full Text] [Related]
6. Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage. Svicher V; Alteri C; Artese A; Zhang JM; Costa G; Mercurio F; D'Arrigo R; Alcaro S; Palù G; Clementi M; Zazzi M; Andreoni M; Antinori A; Lazzarin A; Ceccherini-Silberstein F; Perno CF; Antivir Ther; 2011; 16(7):1035-45. PubMed ID: 22024519 [TBL] [Abstract][Full Text] [Related]
7. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage. Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432 [TBL] [Abstract][Full Text] [Related]
8. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies. Liu S; Fan S; Sun Z J Mol Model; 2003 Oct; 9(5):329-36. PubMed ID: 14517611 [TBL] [Abstract][Full Text] [Related]
9. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5. Morikis D; Rizos AK; Spandidos DA; Krambovitis E Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779 [TBL] [Abstract][Full Text] [Related]
10. Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120. Hsu ST; Bonvin AM Proteins; 2004 May; 55(3):582-93. PubMed ID: 15103622 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART? Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481 [TBL] [Abstract][Full Text] [Related]
12. Theoretical studies on the interactions and interferences of HIV-1 glycoprotein gp120 and its coreceptor CCR5. Da LT; Wu YD J Chem Inf Model; 2011 Feb; 51(2):359-69. PubMed ID: 21284403 [TBL] [Abstract][Full Text] [Related]
13. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains. Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935 [TBL] [Abstract][Full Text] [Related]
14. Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design. Andrianov AM; Anishchenko IV J Biomol Struct Dyn; 2009 Oct; 27(2):179-93. PubMed ID: 19583444 [TBL] [Abstract][Full Text] [Related]
15. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability]. Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807 [TBL] [Abstract][Full Text] [Related]
16. Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loop. Tamamis P; Floudas CA Biophys J; 2013 Sep; 105(6):1502-14. PubMed ID: 24048002 [TBL] [Abstract][Full Text] [Related]
17. Structural analysis of the envelope gp120 V3 loop for some HIV-1 variants circulating in the countries of Eastern Europe. Andrianov AM; Kornoushenko YV; Anishchenko IV; Eremin VF; Tuzikov AV J Biomol Struct Dyn; 2013; 31(7):665-83. PubMed ID: 22888999 [TBL] [Abstract][Full Text] [Related]
18. A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains. Nehete PN; Vela EM; Hossain MM; Sarkar AK; Yahi N; Fantini J; Sastry KJ Antiviral Res; 2002 Dec; 56(3):233-51. PubMed ID: 12406507 [TBL] [Abstract][Full Text] [Related]
19. Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates. Andrianov AM; Veresov VG J Biomol Struct Dyn; 2007 Jun; 24(6):597-608. PubMed ID: 17508782 [TBL] [Abstract][Full Text] [Related]